Phoenix Wound Matrix® is a synthetic, fully bioabsorbable advanced wound care device* designed to harness the innate inflammatory response, promote progression to the proliferative phase, and enable the regeneration of functional, native skin in the wound bed.†
The Phoenix Wound Matrix has FDA 510(k) clearance for use in the treatment of both partial- and full-thickness wounds. Wound types include: diabetic ulcers, venous ulcers, pressure ulcers, arterial/ischemic ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, post laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second degree burns, skin tears) and draining wounds.
The Phoenix Wound Matrix®, a fully resorbable, 3D electrospun device composed of synthetic polymers, is designed to provide a temporary microenvironment that supports endogenous wound healing, allowing for regeneration and remodeling of native tissue in the defect space/wound bed. This device is engineered to promote healthy tissue growth rather than a protracted inflammatory response.†
For over a decade, Nanofiber Solutions, the technical parent company of RenovoDerm®, has worked with progressive surgeons and researchers to develop products designed to mimic the in vivo, microscopic, physical structures and properties of the extracellular matrix (ECM) vital to functional tissue regeneration.